Evidence map›Paper›PMID 31321326›Full record

ArticleHeliyon2019

Hydrophobic nanoprecipitates formed by benzoylphenylureas and β-cyclodextrin inclusion compounds: synthesis, characterization and toxicity against

Vanessa Cristina Estevam Bittencourt, Ana Maria Dos Santos Moreira, Jeferson Gomes da Silva, Antônio Frederico de Freitas Gomides, Cibele Velloso-Rodrigues, Regina Gendzzelevski Kelmann, Leonardo Meneghin Mendonça, Ivana Silva Lula, Ângelo Márcio Leite Denadai

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Intranasal hydrogel of armodafinil hydroxypropyl-β-cyclodextrin inclusion complex for the treatment of post-traumatic stress disorder.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Vanessa Cristina Estevam BittencourtDepartment of Pharmacy, Federal University of Juiz de Fora (UFJF), Campus Governador Valadares, Postal Code: 35010-177, Governador Valadares, Minas Gerais, Brazil.
Ana Maria Dos Santos MoreiraDepartment of Pharmacy, Federal University of Juiz de Fora (UFJF), Campus Governador Valadares, Postal Code: 35010-177, Governador Valadares, Minas Gerais, Brazil.
Jeferson Gomes da SilvaDepartment of Pharmacy, Federal University of Juiz de Fora (UFJF), Campus Governador Valadares, Postal Code: 35010-177, Governador Valadares, Minas Gerais, Brazil.
Antônio Frederico de Freitas GomidesDepartment of Basic Life Sciences, Federal University of Juiz de Fora (UFJF), Campus Governador Valadares, Postal Code: 35010-177, Governador Valadares, Minas Gerais, Brazil.
Cibele Velloso-RodriguesDepartment of Basic Life Sciences, Federal University of Juiz de Fora (UFJF), Campus Governador Valadares, Postal Code: 35010-177, Governador Valadares, Minas Gerais, Brazil.
Regina Gendzzelevski KelmannDepartment of Basic Life Sciences, Federal University of Juiz de Fora (UFJF), Campus Governador Valadares, Postal Code: 35010-177, Governador Valadares, Minas Gerais, Brazil.
Leonardo Meneghin MendonçaDepartment of Basic Life Sciences, Federal University of Juiz de Fora (UFJF), Campus Governador Valadares, Postal Code: 35010-177, Governador Valadares, Minas Gerais, Brazil.
Ivana Silva LulaDepartment of Chemistry, Federal University of Minas Gerais (UFMG), Postal Code: 35010-177, Belo Horizonte, Minas Gerais, Brazil.
Ângelo Márcio Leite DenadaiDepartment of Pharmacy, Federal University of Juiz de Fora (UFJF), Campus Governador Valadares, Postal Code: 35010-177, Governador Valadares, Minas Gerais, Brazil.
Universidade Federal de Juiz de Fora · BRUniversidade Federal de Minas Gerais · BR

Funding

Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing LossR01DC018850 · NIDCD · SCINTILLON INSTITUTE FOR PHOTOBIOLOGY · PI TEITZ, TAL · 2021 to 2025
$2.3M
NIDCD NIH HHS R01 DC018850
6 · The paper itself

Abstract

The aim of this work was to synthesize and characterize the inclusion compounds formed by the complexation of β-cyclodextrin (βCD) with insecticides from the class of benzoylphenylureas (BPUs), named novaluron (NOV) and diflubenzuron (DIF), beyond evaluate their larvicidal activity against

Indexed as

BenzoylphenylureasControlled release systemCyclodextrinsHydrophobic nanoprecipitateInclusion compoundsLarvicidal activityPhysical chemistryThermodynamics

Identifiers

PMID31321326
PMCPMC6612800
OpenAlexW2954616109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.